Premium grade botanicals and synthesized compounds produced in our cutting-edge manufacturing facilities.
The global pharmaceutical sector is undergoing a profound paradigm shift. For decades, synthetic agents like Sinemet (a key levodopa-carbidopa therapeutic combination) have represented the gold standard in dopaminergic replenishment therapy for Parkinson's disease. However, modern pharmaceutical design is increasingly turning to botanical active pharmaceutical ingredients (APIs) and highly purified plant extracts to optimize bioavailability, reduce systemic toxicity, and deliver neuroprotective co-factors that support standard clinical pathways.
Chengdu Chenlv Herb Co., Ltd. sits at this critical intersection of natural organic chemistry and clinical efficacy. As an established pioneer in natural raw materials, we study the pathways of compounds like Levodopa/Carbidopa (Sinemet) to develop synergistic natural compounds—such as high-purity antioxidants (Ergothioneine), mitochondrial stabilizers (Astragaloside A), and clean-label emulsifying agents (Sodium Deoxycholate). These components act as valuable excipients, bio-enhancers, or secondary supportive APIs in modern drug development.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. is a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients.
The evolutionary trajectory of therapeutic delivery systems: from traditional oral formulations to smart nano-carriers.
Pharmaceutical researchers encounter severe pharmacokinetic bottlenecks when developing oral tablet formulations. For instance, classic levodopa-carbidopa systems (such as standard Sinemet tablets) face significant challenges with short half-lives, fluctuating plasma concentrations, and the "wearing-off" effect. Developing continuous, controlled-release matrixes is paramount to establishing stable serum levels. Our technical roadmap addresses these delivery challenges through three strategic pill-formulation vectors:
Implementing advanced cellulose-based polymers and natural mucilage agents to construct a swelling matrix. This regulates the hydration rate of the tablet, ensuring steady, zero-order release kinetics of highly water-soluble APIs over extended gastric transit times.
Utilizing high-purity surfactants and bile salts, such as Taurodeoxycholate Sodium and Sodium Deoxycholate, to formulate self-emulsifying drug delivery systems (SEDDS). This micro-encapsulates active ingredients, greatly enhancing intestinal lymphatic absorption and bypassing hepatic first-pass metabolism.
Co-formulating synthetic dopaminergics with highly bioavailable natural compounds. Integrating ingredients like Troxerutin and Astragaloside A stabilizes blood-brain barrier (BBB) integrity, reducing the neuroinflammatory cascades commonly associated with long-term synthetic drug regimens.
Resolving systemic bottlenecks in B2B sourcing, ingredient standardization, and global pricing dynamics.
Global health product developers and pharmaceutical buyers face rising supply chain instability, shifting regulatory parameters, and volatile ingredient prices. For example, recent supply trends in raw materials like Citrus aurantium highlight the vulnerability of active herbal compounds to seasonal harvests and processing capacity constraints.
Chenlv Herb addresses these challenges by offering comprehensive macro-level solutions. We employ large-scale sourcing agreements, dual-facility buffer stocks, and advanced extraction technologies that maximize extraction yields and minimize batch-to-batch variance. By standardizing manufacturing metrics (such as moisture content, heavy metal limits, and solvent residues), we enable global enterprises to reliably transition from wild-harvested biomass to standardized, clean-label APIs.
Leveraging automated extraction, digital quality tracking, and localized cost advantages to secure global supply chains.
Our Chengdu manufacturing facility utilizes intelligent automation and digital process control (Factory 4.0 paradigm). By implementing real-time chromatography and automated evaporation columns, we guarantee high-efficiency botanical extraction while minimizing energy expenditure.
Global standards, regional compliance validation, and verified product certifications.
Navigating international custom clearances and clinical approvals demands rigorous regulatory documentation. Chenlv Herb ensures seamless entry into markets across North America, Europe, and the Asia-Pacific region by maintaining compliance with international standards. We provide complete dossier support, including Certificate of Analysis (CoA), Allergen declarations, MSDS sheets, and pesticide residual screenings.
Certified under: ISO9001, ISO22000, HALAL, KOSHER, FDA registration, and Good Manufacturing Practice (GMP) protocols.
Providing specialized natural solutions tailored to distinct market segments and therapeutic demands.
Chengdu Chenlv Herb provides structured, transparent contract manufacturing (OEM/ODM) stages.
01
Communicate with customers to determine specific active ingredient specifications and product requirements.
02
Provide a detailed proposal quotation and cost breakdown based on customer quantity and quality requirements.
03
Sign a contract to further discuss the details of cooperation, including milestones and NDAs.
04
Manufacture product pilot samples for analytical laboratory validation and customer verification.
05
After customers confirm the samples, the factory schedules the industrial-scale production order.
06
The quality control laboratory tests the finished products and issues a detailed Certificate of Analysis (CoA).
07
Deliver the finished products to customers via international logistics networks, accompanied by complete custom dossiers and declarations.
Keep pace with shifting market metrics, plant extraction technology advances, and trade events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end, price fluctuations remain dynamic.
As a major gateway for leading China's pharmaceutical industry onto the global stage, CPHI China 2025 will join hands with the 18th China Pharmaceutical Machinery.
Join us to discuss key technical breakthroughs in plant bio-extraction, pharmaceutical standardization, and joint supply chain coordination for global partners.
Addressing core scientific, logistic, and quality validation questions of global pharmaceutical procurement managers.
Synthetic therapeutics like Sinemet (levodopa/carbidopa) Replenish dopamine levels but do not slow cellular neurodegeneration. Botanical APIs like Ergothioneine act as highly targeting antioxidants, clearing toxic free radicals within dopaminergic cells. Furthermore, compounds like Troxerutin protect capillary networks, facilitating a stable and predictable flow of therapeutic active elements across the blood-brain barrier.
Every production batch undergoes strict analytical verification using high-performance liquid chromatography (HPLC) to verify active concentrations, gas chromatography (GC) for residual organic solvents, and inductively coupled plasma mass spectrometry (ICP-MS) to check for heavy metals. Our in-house testing conforms to USP, EP, and ChP validation guidelines.
We utilize long-term advance contracts with localized agricultural cooperatives and agricultural bases to stabilize pricing. Combined with our industrial extraction lines (Factory 4.0), we can extract higher active yields from every raw ton, mitigating global raw material cost swings and providing stable prices to our long-term B2B procurement partners.
We supply a complete regulatory dossier including Drug Master Files (DMF) where applicable, GMP certificates, Allergen statements, Non-GMO assurances, Kosher and Halal compliance certificates, and third-party validation reports for pesticide residues, irradiation, and microbial limits.
Explore our highly standardized phytochemical derivatives, secondary metabolites, and synthesized lipid excipients.
